Covered recipient · General Payments record
VICTORIA LYNN KELL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2021–2024
$861.98
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $337.82 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $135.11 | 19 |
| Novo Nordisk AS | $53.75 | 3 |
| Exeltis, USA Inc. | $34.56 | 2 |
| Amgen Inc. | $29.38 | 2 |
| Astellas Pharma US Inc | $22.04 | 1 |
| Lilly USA, LLC | $17.98 | 1 |
| Organon LLC | $16.98 | 1 |
| PFIZER INC. | $14.10 | 1 |
| GlaxoSmithKline, LLC. | $13.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.48 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446672 | CMS |
| ABBVIE INC. | $2.88 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446674 | CMS |
| ABBVIE INC. | $6.03 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446676 | CMS |
| ABBVIE INC. | $3.40 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446678 | CMS |
| ABBVIE INC. | $18.81 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446680 | CMS |
| ABBVIE INC. | $4.16 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446682 | CMS |
| ABBVIE INC. | $14.85 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446684 | CMS |
| ABBVIE INC. | $0.86 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446686 | CMS |
| ABBVIE INC. | $22.83 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446688 | CMS |
| ABBVIE INC. | $3.48 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446690 | CMS |
| ABBVIE INC. | $24.83 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446692 | CMS |
| ABBVIE INC. | $2.55 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446694 | CMS |
| ABBVIE INC. | $1.92 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446696 | CMS |
| ABBVIE INC. | $2.69 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446698 | CMS |
| ABBVIE INC. | $3.12 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446700 | CMS |
| ABBVIE INC. | $2.26 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446702 | CMS |
| ABBVIE INC. | $12.43 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446704 | CMS |
| ABBVIE INC. | $2.92 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446706 | CMS |
| ABBVIE INC. | $2.61 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107446708 | CMS |
| Amgen Inc. | $14.04 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117595633 | CMS |
| Amgen Inc. | $15.34 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117595635 | CMS |
| Astellas Pharma US Inc | $22.04 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139527168 | CMS |
| Exeltis, USA Inc. | $14.32 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150014543 | CMS |
| Exeltis, USA Inc. | $20.24 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150014545 | CMS |
| GlaxoSmithKline, LLC. | $13.92 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116603360 | CMS |
| Lilly USA, LLC | $17.98 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135974112 | CMS |
| Novo Nordisk Inc | $18.77 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100275630 | CMS |
| Novo Nordisk Inc | $20.49 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100639568 | CMS |
| Novo Nordisk Inc | $14.49 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100259193 | CMS |
| Organon Llc | $16.98 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136193838 | CMS |
| PFIZER INC. | $14.10 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131940749 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.